首頁 > 市場調查報告書 > 食物/飲料

機能性食品

市場調查報告書

商品編碼

1876648

嬰兒配方奶粉蛋白水解物市場機會、成長促進因素、產業趨勢分析及預測（2025-2034年）

Infant Formula Protein Hydrolysates Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: 2025年11月14日 | 出版商:

Global Market Insights Inc. | 英文 210 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024 年全球嬰兒配方奶粉蛋白水解物市場價值為 21 億美元，預計到 2034 年將以 9% 的複合年成長率成長至 51 億美元。

持續成長凸顯了市場對水解蛋白配方奶粉的快速成長需求，這類配方奶粉正成為因過敏或飲食不耐症而需要特殊營養的嬰兒的首選。市場的擴張與食物不耐受嬰兒數量的增加密切相關，促使人們持續採用改良蛋白配方奶粉。長期評估表明，隨著產品創新加速，以及製造商根據新興臨床需求和不斷變化的消費者期望調整解決方案，市場將繼續發展。由於水解蛋白的生產涉及複雜的加工步驟、嚴格的安全評估以及對全球市場監管標準的嚴格遵守，因此高價仍然是該品類的顯著特徵。先進的水解技術，包括酵素法和熱法，有助於生產更容易嬰兒消化且不易引發不良反應的蛋白質。臨床指引支持使用深度水解配方奶粉作為對不耐受標準牛奶蛋白的嬰兒的有效營養選擇。

市場範圍
起始年份	2024
預測年份	2025-2034
起始值	21億美元
預測值	51億美元
複合年成長率	9%

2024年，深度水解配方奶粉佔了45%的市場佔有率，凸顯了其在解決牛奶蛋白過敏問題上的重要作用。這些配方奶粉採用胜肽鏈大小低於3 kDa的深度水解蛋白，有助於降低引發過敏反應的風險，同時滿足關鍵營養需求。

2024年，食物過敏管理領域佔了55%的市場。如此高的市場佔有率反映了水解蛋白在解決與食物不良反應和持續營養問題相關的疾病方面的臨床意義。水解蛋白能夠提高餵食耐受性並降低反應風險，這項特性持續影響醫療保健建議，並推動了醫療和零售通路需求的成長。

2024年，美國嬰兒配方奶粉蛋白水解物市場規模預計將達5.893億美元。兒童食物過敏病例的增加推動了市場成長，而臨床指導和保險認可的支持也促進了產品的普及。該地區對專業營養品的投資意願也支撐了市場的強勁發展勢頭。

嬰兒配方奶粉蛋白水解物市場的主要品牌包括 Perrigo 公司、ByHeart、達能、雅培、Arla Foods Ingredients、Else Nutrition、森永乳業、HiPP、雀巢、Bellamy's Organic、利潔時、Kendamil 和 Biostime International。這些公司專注於多種核心策略以鞏固其競爭地位。許多公司大力投資研發，致力於開發更易消化、蛋白質分解更有效率的配方。此外，各公司也重視臨床驗證，以贏得醫療保健專業人員和照護人員的信任。擴大生產能力和最佳化供應鏈有助於確保產品供應穩定，而與兒科專家的合作則有助於提升品牌信譽。領導品牌積極進行精準行銷，突顯水解蛋白的益處，並提高消費者認知度。

產業生態系分析
- 供應商格局
- 利潤率
- 每個階段的價值增加
- 影響價值鏈的因素
- 中斷
產業影響因素
- 成長促進因素
- 產業陷阱與挑戰
- 市場機遇
成長潛力分析
監管環境
- 北美洲
- 歐洲
- 亞太地區
- 拉丁美洲
- 中東和非洲
波特的分析
PESTEL 分析
價格趨勢
- 按地區
未來市場趨勢
技術與創新格局
- 當前技術趨勢
- 新興技術
專利格局
貿易統計（HS編碼）（註：僅提供重點國家的貿易統計資料）
- 主要進口國
- 主要出口國
永續性和環境方面
- 永續實踐
- 減少廢棄物策略
- 生產中的能源效率
- 環保舉措
碳足跡考量

第4章：競爭格局

介紹
公司市佔率分析
- 按地區
  - 北美洲
  - 歐洲
  - 亞太地區
  - 拉丁美洲
  - 中東和非洲
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
關鍵進展
- 併購
- 合作夥伴關係與合作
- 新產品發布
- 擴張計劃

第5章：市場規模及預測：依產品類型分類，2021-2034年

主要趨勢
深度水解配方（eHF）
- 基於酪蛋白的eHF
- 乳清基eHF
部分水解配方（pHF）
- 基於酪蛋白的pHF
- 乳清基pHF
胺基酸配方（AAF）
米蛋白水解物配方
其他

第6章：市場規模及預測：依應用領域分類，2021-2034年

主要趨勢
食物過敏管理
- 牛奶蛋白過敏症（CMPA）
- 多種食物蛋白不耐症（MFPI）
- 食物蛋白誘發性腸炎症候群（FPIES）
- 嗜酸性粒細胞性胃腸道疾病
胃腸道疾病
- 功能性胃腸疾病
- 吸收不良症候群
- 發炎性腸道疾病
- 結構性胃腸道疾病
生長和營養支持
- 生長發育不良
- 代謝紊亂
- 胰臟功能不全
重症監護和醫院應用
- 新生兒加護病房（NICU）
- 兒科加護病房（PICU）
- 急診申請
其他
- 免疫缺乏疾病
- 神經系統疾病
- 遺傳症候群
- 腫瘤學應用

第7章：市場規模及預測：依最終用途產業分類，2021-2034年

主要趨勢
醫院和醫療保健系統
政府和公共項目
其他

第8章：市場規模及預測：依地區分類，2021-2034年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 澳洲
- 亞太其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第9章：公司簡介

Abbott Laboratories
Reckitt Benckiser
Nestle
Danone
Arla Foods Ingredients
Morinaga Milk Industry
Biostime International
Bellamy's Organic
HiPP GmbH
ByHeart
Else Nutrition
Perrigo Company
Kendamil

簡介目錄

Product Code: 15228

The Global Infant Formula Protein Hydrolysates Market was valued at USD 2.1 billion in 2024 and is estimated to grow at a CAGR of 9% to reach USD 5.1 billion by 2034.

Infant Formula Protein Hydrolysates Market - IMG1

The steady increase highlights the fast-growing demand for hydrolyzed protein formulas, which are becoming a preferred option for infants who require specialized nutrition due to allergies or dietary sensitivities. The expansion of this market is closely linked to the rising number of infants experiencing food-related intolerances, encouraging consistent adoption of formulas with modified proteins. Long-term assessments indicate that the market will continue advancing as product innovation accelerates and manufacturers tailor solutions to emerging clinical needs and shifting consumer expectations. Premium pricing remains a defining characteristic of this category because producing hydrolyzed proteins involves complex processing steps, rigorous safety evaluations, and strict adherence to regulatory standards across global markets. Advanced hydrolysis technologies, including enzymatic and thermal techniques, help create proteins that are easier for infants to digest and less likely to trigger reactions. Clinical guidance supports the use of extensively hydrolyzed formulas as an effective nutritional option for infants who do not tolerate standard cow's milk proteins.

Market Scope
Start Year	2024
Forecast Year	2025-2034
Start Value	$2.1 Billion
Forecast Value	$5.1 Billion
CAGR	9%

The extensively hydrolyzed formula products held a 45% share in 2024, underscoring their strong role in addressing cow's milk protein sensitivity. These formulas use deeply broken-down proteins with peptide sizes below 3 kDa to help lower the chance of triggering reactions while still meeting key nutritional needs.

In 2024, the food allergy management segment represented a 55% share. This large share reflects the clinical relevance of hydrolyzed proteins in addressing conditions linked to adverse food responses and ongoing nutritional concerns. Their ability to support feeding tolerance while lowering reaction risk continues to shape healthcare recommendations, contributing to rising demand across medical and retail channels.

United States Infant Formula Protein Hydrolysates Market generated USD 589.3 million in 2024. The increase in food allergy cases among children has influenced growth, with supportive clinical guidance and insurance recognition helping strengthen adoption. The region's readiness to invest in specialized nutrition also supports strong market momentum.

Key brands active in the Infant Formula Protein Hydrolysates Market include Perrigo Company, ByHeart, Danone, Abbott Laboratories, Arla Foods Ingredients, Else Nutrition, Morinaga Milk Industry, HiPP, Nestle, Bellamy's Organic, Reckitt Benckiser, Kendamil, and Biostime International. Companies in the Infant Formula Protein Hydrolysates Market focus on several core strategies to reinforce their competitive position. Many invest heavily in research to create formulas with improved digestibility and enhanced protein breakdown profiles. Firms also emphasize clinical validation to build trust among healthcare professionals and caregivers. Expanding production capabilities and optimizing supply chains help support consistent product availability, while collaborations with pediatric experts enhance credibility. Leading brands pursue targeted marketing to highlight the benefits of hydrolyzed proteins and widen consumer awareness.

Chapter 1 Methodology & Scope

1.1 Market scope and definition
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Data mining sources
- 1.3.1 Global
- 1.3.2 Regional/Country
1.4 Base estimates and calculations
- 1.4.1 Base year calculation
- 1.4.2 Key trends for market estimation
1.5 Primary research and validation
- 1.5.1 Primary sources
1.6 Forecast model
1.7 Research assumptions and limitations

Chapter 2 Executive Summary

2.1 Industry 360⁰ synopsis
2.2 Key market trends
- 2.2.1 Product type
- 2.2.2 Application
- 2.2.3 End Use Industry
2.3 TAM analysis, 2025-2034
2.4 CXO perspectives: Strategic imperatives
- 2.4.1 Executive decision points
- 2.4.2 Critical success factors
2.5 Outlook and strategic recommendations

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
- 3.1.1 Supplier landscape
- 3.1.2 Profit margin
- 3.1.3 Value addition at each stage
- 3.1.4 Factor affecting the value chain
- 3.1.5 Disruptions
3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.2 Industry pitfalls and challenges
- 3.2.3 Market opportunities
3.3 Growth potential analysis
3.4 Regulatory landscape
- 3.4.1 North America
- 3.4.2 Europe
- 3.4.3 Asia Pacific
- 3.4.4 Latin America
- 3.4.5 Middle East & Africa
3.5 Porter's analysis
3.6 PESTEL analysis
3.7 Price trends
- 3.7.1 By region
3.8 Future market trends
3.9 Technology and innovation landscape
- 3.9.1 Current technological trends
- 3.9.2 Emerging technologies
3.10 Patent landscape
3.11 Trade statistics (HS code) (Note: the trade statistics will be provided for key countries only)
- 3.11.1 Major importing countries
- 3.11.2 Major exporting countries
3.12 Sustainability and environmental aspects
- 3.12.1 Sustainable practices
- 3.12.2 Waste reduction strategies
- 3.12.3 Energy efficiency in production
- 3.12.4 Eco-friendly initiatives
3.13 Carbon footprint considerations

Chapter 4 Competitive Landscape, 2024

4.1 Introduction
4.2 Company market share analysis
- 4.2.1 By region
  - 4.2.1.1 North America
  - 4.2.1.2 Europe
  - 4.2.1.3 Asia Pacific
  - 4.2.1.4 Latin America
  - 4.2.1.5 Middle East & Africa
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Key developments
- 4.6.1 Mergers & acquisitions
- 4.6.2 Partnerships & collaborations
- 4.6.3 New product launches
- 4.6.4 Expansion plans

Chapter 5 Market Size and Forecast, By Product Type, 2021-2034 (USD Billion, Kilo Tons)

5.1 Key trends
5.2 Extensively hydrolyzed formula (eHF)
- 5.2.1 Casein-based eHF
- 5.2.2 Whey-based eHF
5.3 Partially hydrolyzed formula (pHF)
- 5.3.1 Casein-based pHF
- 5.3.2 Whey-based pHF
5.4 Amino acid-based formula (AAF)
5.5 Rice protein hydrolysate formula
5.6 Others

Chapter 6 Market Size and Forecast, By Application, 2021-2034 (USD Billion, Kilo Tons)

6.1 Key trends
6.2 Food allergy management
- 6.2.1 Cow's milk protein allergy (CMPA)
- 6.2.2 Multiple food protein intolerance (MFPI)
- 6.2.3 Food protein-induced enterocolitis syndrome (FPIES)
- 6.2.4 Eosinophilic gastrointestinal disorders
6.3 Gastrointestinal disorders
- 6.3.1 Functional gastrointestinal disorders
- 6.3.2 Malabsorption syndromes
- 6.3.3 Inflammatory bowel conditions
- 6.3.4 Structural gastrointestinal disorders
6.4 Growth & nutritional support
- 6.4.1 Failure to thrive
- 6.4.2 Metabolic disorders
- 6.4.3 Pancreatic insufficiency
6.5 Critical care & hospital applications
- 6.5.1 Neonatal intensive care unit (NICU)
- 6.5.2 Pediatric intensive care unit (PICU)
- 6.5.3 Emergency department applications
6.6 Others
- 6.6.1 Immunodeficiency disorders
- 6.6.2 Neurological conditions
- 6.6.3 Genetic syndromes
- 6.6.4 Oncological applications

Chapter 7 Market Size and Forecast, By End Use Industry, 2021-2034 (USD Billion, Kilo Tons)

7.1 Key trends
7.2 Hospital & healthcare systems
7.3 Government & public programs
7.4 Others

Chapter 8 Market Size and Forecast, By Region, 2021-2034 (USD Billion, Kilo Tons)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 UK
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 India
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 Australia
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East & Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East & Africa